Company intelligence / Profile preview

MediNect

Belfast, Northern Ireland, United Kingdommedinect.co.uk ↗

Ownership: Private
Development stage: Preclinical

Overview

MediNect is a UK-based preclinical CRO specializing in ophthalmic drug development, particularly retinal diseases. The company provides expertise and in vivo models to support biotech and biopharma companies in optimizing their preclinical portfolios. It does not have its own clinical pipeline but collaborates with clients to advance their therapeutic programs

Therapeutic areas: Ophthalmology
Modalities: Gene therapySmall moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Not specifically listed; works with various biotech and biopharma companies as clients

Beyond the preview

Go deeper on MediNect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediNect.

Explore the full profile